Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.

被引：21
|
作者：
Lugtenburg, Pieternella J.
Brown, Peter de Nully
van der Holt, Bronno
D'Amore, Francesco
Koene, Harry R.
Berenschot, Henriette W.
Fijnheer, Rob
Loosveld, Olaf
Bohmer, Lara H.
Pruijt, Hans
Verhoef, Gregor
Hoogendoorn, Mels
de Kan, Romko
Van Imhoff, Gustaaf Willem
van Hooije, Christel
Lam, King H.
de Keizer, Bart
de Jong, Daphne
Hoekstra, Otto S.
Zijlstra, Josee M.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7504
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
    Patel, Ankit
    Bhatt, Niraj
    Prakash, S. S.
    Biswas, Ghanashyam
    Nagarkar, Rajnish
    Roy, Bodhisatta
    Samal, Priyanka
    Agrawal, Narendra
    Meshram, Sushil
    Kaushal, Ashish
    Satheesh, C. T.
    Wategaonkar, Ravikumar
    Thiagarajan, Kasi Viswanathan
    Jain, Kartikeya
    Vijayaveeran, P.
    Mukherjee, Kalyan
    Singh, Kishore
    Patil, Tushar
    Jain, Amit
    Dolai, Tuphan Kanti
    Jain, Minish
    Hingmire, Sachin
    Gupta, Tara Chand
    Lakshmaiah, K. C.
    Rajamanickam, Deepan
    Nemade, Bhushan
    Goyal, Vikash
    Mahato, Pinaki
    Mendiratta, Sanjeev Kumar
    Doshi, Maulik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (06) : 457 - 468
  • [22] Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
    Ankit Patel
    Niraj Bhatt
    S. S. Prakash
    Ghanashyam Biswas
    Rajnish Nagarkar
    Bodhisatta Roy
    Priyanka Samal
    Narendra Agrawal
    Sushil Meshram
    Ashish Kaushal
    C. T. Satheesh
    Ravikumar Wategaonkar
    Kasi Viswanathan Thiagarajan
    Kartikeya Jain
    P. Vijayaveeran
    Kalyan Mukherjee
    Kishore Singh
    Tushar Patil
    Amit Jain
    Tuphan Kanti Dolai
    Minish Jain
    Sachin Hingmire
    Tara Chand Gupta
    K. C. Lakshmaiah
    Deepan Rajamanickam
    Bhushan Nemade
    Vikash Goyal
    Pinaki Mahato
    Sanjeev Kumar Mendiratta
    Maulik Doshi
    Cancer Chemotherapy and Pharmacology, 2023, 91 : 457 - 468
  • [23] CHOP chemotherapy plus rituximab compared with CHOP alone in patients with diffuse large B-cell lymphoma, from Indian subcontinent.
    Linga, Vijay Gandhi
    Digumarti, Raghunadharao
    Maddi, Rahul Narayan
    Goteke, Vamshi Krishna Reddy
    Gundeti, Sadashivudu
    Thota, Narender Kumar
    Coca, Pragnya
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
    Ritsuko Seki
    Koichi Ohshima
    Koji Nagafuji
    Tomoaki Fujisaki
    Naokuni Uike
    Fumio Kawano
    Hisashi Gondo
    Shigeyoshi Makino
    Tetsuya Eto
    Yukiyoshi Moriuchi
    Fumihiro Taguchi
    Tomohiko Kamimura
    Hiroyuki Tsuda
    Ryosuke Ogawa
    Kazuya Shimoda
    Kiyoshi Yamashita
    Keiko Suzuki
    Hitoshi Suzushima
    Kunihiro Tsukazaki
    Masakazu Higuchi
    Atae Utsunomiya
    Masahiro Iwahashi
    Yutaka Imamura
    Kazuo Tamura
    Junji Suzumiya
    Minoru Yoshida
    Yasunobu Abe
    Tadashi Matsumoto
    Takashi Okamura
    International Journal of Hematology, 2010, 91 : 258 - 266
  • [25] Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
    Seki, Ritsuko
    Ohshima, Koichi
    Nagafuji, Koji
    Fujisaki, Tomoaki
    Uike, Naokuni
    Kawano, Fumio
    Gondo, Hisashi
    Makino, Shigeyoshi
    Eto, Tetsuya
    Moriuchi, Yukiyoshi
    Taguchi, Fumihiro
    Kamimura, Tomohiko
    Tsuda, Hiroyuki
    Ogawa, Ryosuke
    Shimoda, Kazuya
    Yamashita, Kiyoshi
    Suzuki, Keiko
    Suzushima, Hitoshi
    Tsukazaki, Kunihiro
    Higuchi, Masakazu
    Utsunomiya, Atae
    Iwahashi, Masahiro
    Imamura, Yutaka
    Tamura, Kazuo
    Suzumiya, Junji
    Yoshida, Minoru
    Abe, Yasunobu
    Matsumoto, Tadashi
    Okamura, Takashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 258 - 266
  • [26] Phase II study of Rituximab in combination with CHOP chemotherapy and GMCSF (Leukine) in patients with previously untreated diffuse large cell lymphoma (DLCL) and mantle cell lymphoma (MCL).
    Venugopal, P
    Wooldridge, JE
    Yunus, F
    Hari, P
    Gregory, SA
    Adler, SS
    Enschede, SH
    Obrien, T
    Odonnell, K
    Woock, S
    BLOOD, 2001, 98 (11) : 251B - 251B
  • [27] Rituximab Maintenance Therapy in Diffuse Large B-Cell Lymphoma in a Multicenter Prospective Randomised Phase II Study
    Witzens-Harig, Mathias
    Benner, Axel
    Rieger, Michael
    McClanahan, Fabienne
    Hensel, Manfred
    Neben, Kai
    Dreger, Peter
    Lengfelder, Eva
    Schmidt-Wolf, Ingo
    Kraemer, Alwin
    Ho, Anthony D.
    BLOOD, 2011, 118 (21) : 1580 - 1581
  • [28] Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma
    Tilly, H.
    Morschhauser, F.
    Salles, G.
    Casasnovas, R-O
    Feugier, P.
    Molina, T. J.
    Jardin, F.
    Terriou, L.
    Haioun, C.
    Coiffier, B.
    LEUKEMIA, 2013, 27 (01) : 252 - 255
  • [29] Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma
    H Tilly
    F Morschhauser
    G Salles
    R-O Casasnovas
    P Feugier
    T J Molina
    F Jardin
    L Terriou
    C Haioun
    B Coiffier
    Leukemia, 2013, 27 : 252 - 255
  • [30] Rituximab maintenance therapy in diffuse large B-cell lymphoma in a multicenter prospective randomised phase II study
    Witzens-Harig, M.
    Benner, A.
    Rieger, M.
    McClanahan, F.
    Hensel, M.
    Neben, K.
    Dreger, P.
    Lengfelder, E.
    Schmidt-Wolf, I
    Kraemer, A.
    Ho, A. D.
    ONKOLOGIE, 2012, 35 : 86 - 86
12345